267 related articles for article (PubMed ID: 8974354)
1. Collagen breakdown products as markers of fibrosis and cirrhosis.
Niemelä O
Alcohol Alcohol Suppl; 1994; 2():345-52. PubMed ID: 8974354
[TBL] [Abstract][Full Text] [Related]
2. [Connective tissue polypeptides in serum: new parameters of connective tissue synthesis and degradation in liver fibrosis].
Schuppan D
Z Gastroenterol; 1992 Mar; 30 Suppl 1():29-34. PubMed ID: 1449013
[TBL] [Abstract][Full Text] [Related]
3. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats.
Boigk G; Stroedter L; Herbst H; Waldschmidt J; Riecken EO; Schuppan D
Hepatology; 1997 Sep; 26(3):643-9. PubMed ID: 9303494
[TBL] [Abstract][Full Text] [Related]
4. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
[TBL] [Abstract][Full Text] [Related]
5. Aminoterminal propeptide of type III procollagen: a marker of hepatic fibrosis after bile duct obstruction in the monkey.
Ruf G; Mappes HJ; Koch H; Baumgartner U; Hagmann W; Farthmann EH
Hepatogastroenterology; 1996; 43(7):121-6. PubMed ID: 8682446
[TBL] [Abstract][Full Text] [Related]
6. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease.
Lieber CS; Weiss DG; Paronetto F;
Alcohol Clin Exp Res; 2008 Jun; 32(6):1031-9. PubMed ID: 18422837
[TBL] [Abstract][Full Text] [Related]
7. Two assays for measuring fibrosis: reverse transcriptase-polymerase chain reaction of collagen alpha(1) (III) mRNA is an early predictor of subsequent collagen deposition while a novel serum N-terminal procollagen (III) propeptide assay reflects manifest fibrosis in carbon tetrachloride-treated rats.
Kauschke SG; Knorr A; Heke M; Kohlmeyer J; Schauer M; Theiss G; Waehler R; Burchardt ER
Anal Biochem; 1999 Nov; 275(2):131-40. PubMed ID: 10552896
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests.
Gressner OA; Weiskirchen R; Gressner AM
Clin Chim Acta; 2007 Jun; 381(2):107-13. PubMed ID: 17399697
[TBL] [Abstract][Full Text] [Related]
9. The aminoterminal propeptide of type III procollagen. Studies on physiology and pathophysiology.
Jensen LT
Dan Med Bull; 1997 Feb; 44(1):70-8. PubMed ID: 9062765
[TBL] [Abstract][Full Text] [Related]
10. An inverse relationship between markers of fibrogenesis and collagen degradation in patients with or without alcoholic liver disease.
Koivisto H; Hietala J; Niemelä O
Am J Gastroenterol; 2007 Apr; 102(4):773-9. PubMed ID: 17222322
[TBL] [Abstract][Full Text] [Related]
11. Serum concentrations of laminin P1 and aminoterminal propeptide of type III procollagen in sickle cell disease.
Bolarin DM; Swerdlow P; Wallace AM; Littsey L
Haematologia (Budap); 1998; 29(1):51-8. PubMed ID: 9704258
[TBL] [Abstract][Full Text] [Related]
12. [Serum markers of liver fibrosis].
Schuppan D; Jax C; Hahn EG
Dtsch Med Wochenschr; 1999 Oct; 124(41):1213-8. PubMed ID: 10572522
[No Abstract] [Full Text] [Related]
13. Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice.
Higashiyama R; Moro T; Nakao S; Mikami K; Fukumitsu H; Ueda Y; Ikeda K; Adachi E; Bou-Gharios G; Okazaki I; Inagaki Y
Gastroenterology; 2009 Oct; 137(4):1459-66.e1. PubMed ID: 19596008
[TBL] [Abstract][Full Text] [Related]
14. Biochemical markers, extracellular components in liver fibrosis and cirrhosis.
Bolarin DM; Azinge EC
Nig Q J Hosp Med; 2007; 17(1):42-52. PubMed ID: 17688172
[TBL] [Abstract][Full Text] [Related]
15. Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver.
Tsukamoto T; Yamamoto T; Ikebe T; Takemura S; Shuto T; Kubo S; Hirohashi K; Kinoshita H
Hepatogastroenterology; 2004; 51(57):777-80. PubMed ID: 15143915
[TBL] [Abstract][Full Text] [Related]
16. [Progress in the diagnosis of chronic liver disease: diagnostic activity in liver fibrosis and cirrhosis].
Pott G; Gerlach U
Leber Magen Darm; 1982 Aug; 12(4):141-4. PubMed ID: 6752610
[TBL] [Abstract][Full Text] [Related]
17. [N-terminal peptide of type III procollagen in serum and bronchoalveolar fluid as a marker of collagen metabolism in chronic interstitial lung diseases].
Siemińska A
Przegl Lek; 1996; 53(7):574-8. PubMed ID: 8975295
[TBL] [Abstract][Full Text] [Related]
18. Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipients.
Teppo AM; Törnroth T; Honkanen E; Grönhagen-Riska C
Transplantation; 2003 Jun; 75(12):2113-9. PubMed ID: 12829921
[TBL] [Abstract][Full Text] [Related]
19. Biochemical markers of types I and III collagen and limited joint mobility in type 1 diabetic patients.
Arkkila PE; Koskinen PJ; Kantola IM; Rönnemaa T; Seppänen E; Viikari JS
Acta Diabetol; 2003 Dec; 40(4):151-5. PubMed ID: 14740273
[TBL] [Abstract][Full Text] [Related]
20. [Liver fibrosis. 2].
Hahn EG; Ott U; Martini GA
Z Gastroenterol; 1980 Oct; 18(10):507-23. PubMed ID: 6109405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
